Medical Devices
Global Breast Lesion Localization Market Research and Forecast, 2018-2023
Global breast lesion localization market, size, share, market intelligence, company profiles, market trends, growth, strategy, research and analysis report, forecast 2018-2023
Breast lesion localization procedure is now as popular as mammography or any other imaging procedure. Breast lesion localization is used in almost 50% of all lumpectomy and surgical biopsy procedures to confirm the removal of the targeted lesion. The demand for breast lesion localization procedure is increasing due to the high prevalence of breast cancer across the globe. Further, increasing breast cancer screening programs such as National Breast and Cervical Cancer Early Detection Program (NBCCEDP) and Women’s Cancer Screening Program, raise the awareness among people which in turns drives the growth of the market significantly during the forecast period. Rising healthcare expenditure in developing economies is also boosting the growth of the breast lesion localization market across the globe.
However, stringent government regulation for approvals and complex procedure and risk from localization devices are restraining the market. Introduction of new technologies such as RFID technology is creating enormous opportunity for the growth of the breast lesion localization market. technological advancement enables simpler, safer and accurate localization which improves the collaboration between radiologists and surgeons.
Browse full report at Global Breast Lesion Localization Market
The global breast lesion localization market is segmented on the basis of type and end-user. Based on the type, the market is segmented into wire-guided localization, radioisotope localization, and magnetic tracer. The radioisotope localization includes radioactive seed localization and radio occult lesion localization. The wire-guided localization has a significant market and is a commonly used the procedure for the breast lesion localization. The end-user segment is segmented into hospitals, diagnostic center, and research institute.
The global breast lesion localization market is further segmented on the basis of geography include North America, Europe, Asia-Pacific and rest of the world. North America is expected to hold a dominant position in the global breast lesion localization market, followed by Europe. The high prevalence of breast cancer and increasing breast cancer screening programs significantly contributing towards the market growth in the region. The Asia-Pacific region is projected to exhibit the fastest growth in the global breast lesion localization market during the forecast period attributed to rising healthcare expenditure in developing economies and growing awareness among people regarding breast cancer.
The key players contributing to the growth of the global breast lesion localization market are C.R. Bard, Cook Medical, Somatex Medical Technologies GmbH, and others. To endure in the competitive market, these players adopt various strategies such as mergers and acquisitions, geographical expansions, joint ventures and product launch for the growth of the market.
The report covers
- Comprehensive research methodology of the global breast lesion localization market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global breast lesion localization market.
- Insights about market determinants which are stimulating the global breast lesion localization market.
- Detailed and extensive market segments with regional distribution of forecast
- Extensive profiles and recent developments of market players.
0 Comments